Showing results (91-100 of 100) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Physical Review Letters|June 25, 2016
Evidence for Eight-Node Mixed-Symmetry Superconductivity in a Correlated Organic MetalDaniel Guterding, Sandra Diehl, Michaela Altmeyer, et al.The Journal of Biological Chemistry|February 17, 2005
A novel chloride channel in Drosophila melanogaster is inhibited by protonsKatrin Schnizler, Beate Saeger, Carsten Pfeffer, et al.Translational Psychiatry|September 12, 2023
Baseline levels of miR-223-3p correlate with the effectiveness of electroconvulsive therapy in patients with major depressionLalit Kaurani, Matthias Besse, Isabel Methfessel, et al.Psychopharmacology|December 18, 2012
Pharmacological and behavioral profile of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-6-chinolincarboxamide (EVP-5141), a novel α7 nicotinic acetylcholine receptor agonist/serotonin 5-HT3 receptor antagonistFrank G Boess, Jean de Vry, Christina Erb, et al.Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|March 15, 2021
[Use of electroconvulsive therapy in adolescents - A retrospective survey on 12- to 17-year-old patients at three university hospitals in Germany]Isabel Methfessel, Steffen Weirich, Boris Rothermel, et al.Neuropharmacology|November 17, 2011
EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptorsJos Prickaerts, Nick P van Goethem, Richard Chesworth, et al.The Journal of Pharmacology and Experimental Therapeutics|February 20, 2007
The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodentsFrank G Boess, Jean De Vry, Christina Erb, et al.The Journal of ECT|June 14, 2022
Electroconvulsive Therapy in Children and Adolescents in Germany-A Case Series From 3 University HospitalsSebastian Karl, Isabel Methfessel, Steffen Weirich, et al.Brain Stimulation|December 18, 2018
Electroconvulsive therapy induced gray matter increase is not necessarily correlated with clinical data in depressed patientsAlexander Sartorius, Traute Demirakca, Andreas Böhringer, et al.International Journal of Biological Research in Pregnancy|January 1, 1982
The antenatal use of ambroxol (bromhexine metabolite VIII) to prevent hyaline membrane disease: a controlled double-blind studyR R Wauer, G Schmalisch, K Menzel, et al.Pageof 10